
Developer of High-End Ophthalmic Surgical Equipment

Major Clinical Breakthrough: Chinese Ophthalmic Devices Achieve New Milestone!2026June 16,Rhino HealthFirst Domestic ApprovalThe Genesis combined phacoemulsification and vitrectomy system has been officially installed at the 411 Hospital Affiliated to Shanghai University.On June 17, the first in-house ophthalmic surgery was successfully completed, with stable intraoperative performance and optimal procedural compatibility, delivering a flawless clinical outcome.

GenesisEnsuring the Smooth Conduct of Ophthalmic Surgery
The 411 Hospital Affiliated to Shanghai University was originally built inA Grade 3A comprehensive public hospital established in 1949, with decades of expertise in ophthalmic clinical practice. Its ophthalmology team specializes in the diagnosis and treatment of complex cataracts and challenging fundus diseases. Adhering to stringent clinical quality control standards, it serves as a benchmark ophthalmic institution in the Shanghai region. The hospital’s rigorous equipment admission criteria further attest to the robust capabilities of Genesis devices.
Dr. Xu Zequan, Ophthalmologist at Shanghai 411 Hospital, stated after the surgery“Having performed surgeries for so many years,Rhino Health’s device has renewed my hope in domestically produced equipment. Its performance is nearly on par with that of established imported brands, demonstrating excellent phacoemulsification capabilities and a high vitrectomy cutting rate. Moreover, it requires almost no learning curve, allowing younger physicians at primary-care hospitals to quickly master its operation."At the current stage, national policy is to vigorously support the development of domestically produced equipment. I have confidence in Rhino Health."

Holding the Trophy, Celebrating Successful Installation

Group Photo of the Rhino Health Team and the Hospital's Ophthalmology Team
Excellent Clinical Experience: A Message from Dr. Xu Zequan
This installation isXiranGenesisPhaco-Vitrectomy Integrated SystemNational No.10 units, the first unit installed in Shanghai.For a long time, the integrated phacoemulsification and vitrectomy systemThe market is dominated by overseas brands.,Imported equipment is more expensive and has a longer after-sales response cycle.。As the first domestically produced integrated device approved for market launch, Genesis matches the core performance of imported counterparts and offers rapid localized service.Providing New Options to Break Down Barriers for Imported Medical Equipment。
AcademicWetlab has garnered widespread acclaim and achieved stable clinical implementation in tertiary hospitals. Rhino Health is fulfilling its mission of domestic substitution through its proprietary core technologies, witnessing the breakthrough and rise of China's national technological strength in ophthalmology.
XiranIntroduction to the Genesis Integrated Phacoemulsification and Vitrectomy System

